ReviewBioengineering (Basel, Switzerland)2026
Nano-Based 3D Printed Scaffold for Bone Tissue Engineering.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
3D bioprinting technology has made great strides in the field of bone tissue engineering. It has been able to create personalized biological structures on a macroscopic scale. In terms of microstructure bionics, 3D printing technology has also made some progress in recent years. The use of nanotechnology and drug delivery technology has provided a microenvironment that is more compatible with cell growth. Finally, it is possible to bridge the gap between engineered organizational structures and natural tissues. In this work, we summarize the widely used 3D bioprinting methods and the preparation of bioinks. Next, the classification of bone tissue engineering scaffold materials and nanomaterials for loading is briefly introduced. Then the technical shortcomings of current nanotechnology-based 3D bioprinting are described, along with the corresponding improvements. Finally, we summarize the prospects of nano-based 3D bioprinting technology in bone tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.